3-quinuclidinyl-4-iodobenzilate has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Chisholm, JA; Owens, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Colloby, SJ; Firbank, MJ; McKeith, IG; O'Brien, JT; Owens, J; Pakrasi, S; Perry, EK; Williams, ED; Wyper, DJ | 1 |
| Boulay, SF; Cohen, VI; Rayeq, MR; Reba, RC; Sood, VK; Zeeberg, BR | 1 |
| Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR | 1 |
| Zeeberg, B | 1 |
| Albert, M; Eckelman, WC; Gibson, RE; Hill, TC; Holman, BL; Reba, RC | 1 |
1 trial(s) available for 3-quinuclidinyl-4-iodobenzilate and Alzheimer Disease
| Article | Year |
|---|---|
Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Quinuclidinyl Benzilate; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Muscarinic M1; Receptors, Muscarinic; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Exametazime; Tissue Distribution; Treatment Outcome | 2003 |
5 other study(ies) available for 3-quinuclidinyl-4-iodobenzilate and Alzheimer Disease
| Article | Year |
|---|---|
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Female; Humans; Iodine Radioisotopes; Male; Quinuclidinyl Benzilate; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon | 2007 |
Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype.
Topics: Alzheimer Disease; Animals; Autoradiography; Binding, Competitive; Brain; Brain Mapping; Cerebral Cortex; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Muscarinic Antagonists; Quinuclidinyl Benzilate; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptors, Muscarinic | 1996 |
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |
Concerning the distribution of cerebral muscarinic acetylcholine receptors in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Humans; Quinuclidinyl Benzilate; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon | 1991 |
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
Topics: Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Humans; Iodine Radioisotopes; Iofetamine; Male; Middle Aged; Quinuclidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Muscarinic; Tomography, Emission-Computed | 1985 |